Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.cbcpharma.com | |
Market Cap | 83.00 Cr. | |
Enterprise Value(EV) | 101.94 Cr. | 2023-03 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 1.20 | Trailing Twelve Months Ending 2023-03 |
Price-Earning Ratio (PE) | 91.81 | Trailing Twelve Months Ending 2023-03 |
Industry PE | 37.76 | Trailing Twelve Months Ending 2023-03 |
Book Value / Share | 36.42 | Trailing Twelve Months Ending 2023-03 |
Price to Book Value | 3.02 | Calculated using Price: 110.00 |
Dividend Yield | 0.00 | Period Ending 2022-03 |
No. of Shares Subscribed | 0.75 Cr. | 7,545,056 Shares |
FaceValue | 10 | |
About Chandra Bhagat Pharma Ltd. | ||
The company is engaged in the marketing of lifesaving medicines in India such as Cardiovascular, Antineoplastic, Antibiotics and Hormones medicines. It provides pharmaceuticals and special chemical products in the Indian and international market. It has wide range of products portfolio of pharmaceutical formulation including IV & IM range Injections, few tablets to cater the Domestic & Export Market. |
1 Day |
|
|
1 Week |
|
-7.49% |
1 Month |
|
-16.67% |
3 Month |
|
-15.38% |
6 Month |
|
+13.40% |
1 Year |
|
+3.53% |
2 Year |
|
-21.43% |
5 Year |
|
|
10 Year |
|
9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | 7.53 | 6.89 | 5.38 | 9.33 | 13.44 | 6.46 | 1.67 | 0.78 | 3.19 | |
Return on Capital Employed (%) | 11.66 | 10.40 | 12.62 | 14.34 | 17.58 | 13.40 | 7.16 | 7.63 | 8.83 | |
Return on Assets (%) | 1.27 | 1.16 | 0.82 | 1.32 | 1.82 | 0.98 | 0.40 | 0.26 | 1.10 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03* Rs. Cr. |
Shh. Funds | 6 | 6 | 7 | 7 | 8 | 14 | 26 | 26 | 27 | 27 | |
Non Curr. Liab. | 0 | 0 | 0 | 11 | 21 | 16 | 15 | 13 | 8 | 6 | |
Curr. Liab. | 26 | 36 | 38 | 37 | 29 | 53 | 34 | 33 | 38 | 27 | |
Minority Int. | |||||||||||
Equity & Liab. | 32 | 42 | 44 | 56 | 58 | 83 | 75 | 72 | 72 | 61 | |
Non Curr. Assets | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 2 | |
Curr. Assets | 31 | 41 | 44 | 55 | 57 | 81 | 73 | 70 | 71 | 59 | |
Misc. Exp. not W/O | 0 | 1 | 1 | 1 | 1 | ||||||
Total Assets | 32 | 42 | 44 | 56 | 58 | 83 | 75 | 72 | 72 | 61 |
Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Net Sales | 35 | 48 | 61 | 80 | 90 | 97 | 106 | 94 | 71 | 94 | |
Other Income | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 2 | ||
Total Income | 35 | 49 | 61 | 80 | 90 | 98 | 107 | 94 | 71 | 96 | |
Total Expenditure | -35 | -46 | -58 | -76 | -85 | -92 | -102 | -91 | -67 | -91 | |
PBIDT | 0 | 2 | 3 | 5 | 5 | 5 | 5 | 4 | 4 | 4 | |
Interest | -2 | -2 | -4 | -4 | -4 | -4 | -3 | -4 | -3 | ||
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Taxation | 0 | 0 | 0 | 0 | 0 | -1 | 0 | 0 | 0 | 0 | |
Exceptional Items | |||||||||||
PAT | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 1 | |
Adjusted EPS | 9 | 8 | 10 | 8 | 2 | 3 | 1 | 0 | 0 | 1 |
Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | -9 | -6 | 4 | -7 | 8 | 12 | |||||
Cash Fr. Inv. | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Cash Fr. Finan. | 8 | 7 | -4 | 7 | -6 | -10 | |||||
Net Change | -1 | 0 | 0 | 0 | 2 | 3 | |||||
Cash & Cash Eqvt | 1 | 1 | 0 | 0 | 3 | 6 |
Sun, 01 Oct 2023
Closure of Trading Window Disclosure for Closure of Trading Window. |
Sat, 30 Sep 2023
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report Scrutinizers Report on the Annual General Meeting of the Company. |
Sat, 30 Sep 2023
Shareholder Meeting / Postal Ballot-Outcome of AGM Proceeding of Annual General Meeting held on 30th September 2023. |
Thu, 28 Sep 2023 |
|
|
|
|
|